compound VII [WO2021149692A1]   Click here for help

GtoPdb Ligand ID: 11926

Antimalarial Ligand
Compound class: Synthetic organic
Comment: This is the most potent antimalarial compound from a novel series of diaminopyridines claimed in Eisai's patent WO2021149692A1 [1].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 10
Topological polar surface area 133.45
Molecular weight 515.15
XLogP 4.72
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(c1cc(c(nc1N)N)n1cnc(n1)C1(CC1)C(F)(F)F)NCc1ccc(cc1)OCC(F)(F)F
Isomeric SMILES Nc1c(C(=O)NCc2ccc(cc2)OCC(F)(F)F)cc(c(n1)N)n1nc(nc1)C1(CC1)C(F)(F)F
InChI InChI=1S/C21H19F6N7O2/c22-20(23,24)9-36-12-3-1-11(2-4-12)8-30-17(35)13-7-14(16(29)32-15(13)28)34-10-31-18(33-34)19(5-6-19)21(25,26)27/h1-4,7,10H,5-6,8-9H2,(H,30,35)(H4,28,29,32)
InChI Key FIWILGQIZHDAQG-UHFFFAOYSA-N
Guide to Malaria Pharmacology Comments
Potential Target/Mechanism Of Action: descriptive content in patent WO2021149692 alludes to compound VII being a P. falciparum GPI-anchored wall transfer protein 1 (PfGWT1) inhibitor [1].